Cancer patients who responded to balstilimab can now continue treatment through expanded access
NCT ID NCT05572970
First seen May 14, 2026 · Last updated May 14, 2026
Summary
This expanded access study offers balstilimab alone or combined with zalifrelimab to cancer patients who previously received these drugs in a clinical trial and saw benefit. The goal is to allow continued treatment for those who qualify. Participants must have completed the earlier study's requirements.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arizona Oncology Associates
AVAILABLETucson, Arizona, 85711, United States
-
Hoag Gynecologic Oncology
AVAILABLENewport Beach, California, 92663, United States
-
Texas Oncology
AVAILABLEFlower Mound, Texas, 75028, United States
-
The Ohio State University Wexner Medical Center
AVAILABLEColumbus, Ohio, 43212, United States
-
University of Alabama at Birmingham
AVAILABLEBirmingham, Alabama, 35249, United States
-
University of California, San Francisco Medical Center
AVAILABLESan Francisco, California, 94158, United States
-
Women & Infants Hospital of Rhode Island
AVAILABLEProvidence, Rhode Island, 02905, United States
Conditions
Explore the condition pages connected to this study.